Name: Tenaya Therapeutics, Inc. (TNYA) Financial Statements
Creator: FinSpry

Tenaya Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Tenaya Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	8.47	0.00	0.00	0.00	0.00
Gross Profit	-8.47	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	86.74	98.04	94.54	54.39	31.10
Selling, General & Administrative	29.21	33.16	31.08	18.41	7.81
Operating Expenses	115.95	131.19	125.62	72.81	38.91
Operating Income	-115.95	-131.19	-125.62	-72.81	-38.91
Other Income/Expense
Interest Income	4.74	7.06	1.95	0.11	0.09
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	0.08	0.05	0.00	-0.02	0.39
Income
Income Before Tax	-111.13	-124.08	-123.67	-72.72	-38.40
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-111.13	-124.08	-123.67	-72.72	-38.40
Net Income - Continuous Operations	-111.13	-124.08	-123.67	-72.72	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-107.48	-122.51	-119.15	-69.85	-36.43
EBIT	-115.95	-131.19	-125.62	-72.81	-38.91
Depreciation & Amortization	8.47	8.69	6.47	2.96	2.48
Earnings Per Share
Basic EPS	-1.00	-2.00	-3.00	-4.00	-39.00
Diluted EPS	-1.00	-2.00	-3.00	-4.00	-39.00
Basic Shares Outstanding	84.82	73.79	44.82	17.73	0.97
Diluted Shares Outstanding	84.82	73.79	44.82	17.73	0.97